Japan (JP)

Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials (2025) Schmieder R, Hettrick DA, Böhm M, Kandzari DE, Kario K, Mahfoud F, Tsioufis K, et al. Journal article Quantum gravity, hydrodynamics and emergent cosmology: a collection of perspectives (2025) Ben Achour J, Benedetti D, Bojowald M, Brandenberger R, Butera S, Ferrero R, Giacomini F, et al. Journal article Effective Thermal Conductivity of Cyclohexane-Based Nanofluids Containing Cerium Dioxide Nanoparticles with Chemisorbed Organic Shell (2025) Bioucas F, Wu W, Stiegler L, Peukert W, Walter J, Adschiri T, Yoko A, et al. Journal article, Original article A Flexible Photovoltaic Fatigue Factor for Quantification of Mechanical Device Performance (2025) Sun L, Fukuda K, Guo R, Castriotta LA, Forberich K, Zhou Y, Someya T, et al. Journal article The NewAthena mission concept in the context of the next decade of X-ray astronomy (2025) Cruise M, Guainazzi M, Aird J, Carrera FJ, Costantini E, Corrales L, Dauser T, et al. Journal article Sex-Dependent Variations in Gene Expression in Corneal Endothelial Cells among Healthy Individuals and Patients with Fuchs Endothelial Corneal Dystrophy (2025) Nakagawa T, Tateishi A, Tokuda Y, Nakano M, Tashiro K, Tourtas T, Schlötzer-Schrehardt U, et al. Journal article An Icosahedral 55-Atom Iron Hydride Cluster Protected by Tri-tert-butylphosphines (2025) Higaki T, Tanaka K, Izu H, Oishi S, Kawamoto K, Tada M, Sameera WM, et al. Journal article Meeting report – Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseases (2025) Waschke J, Amagai M, Becker C, Delmar M, Duru F, Garrod DR, Gerull B, et al. Journal article Introducing the OECD guidance document on occupational biomonitoring: A harmonized methodology for deriving occupational biomonitoring levels (OBL) (2025) Hopf NB, Bessems J, Santonen T, Viegas S, Casteleyn L, Poddalgoda D, Lamkarkach F, et al. Journal article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article